Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024 Althea has completed a company-wide review as it looks to cut costs and shore up its […]
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
Althea losses rise but shareholders told to expect ‘significant upside’ by Steve Jones February 28, 2023April 30, 2024
Survivors of dotcom boom and bust keep us focused, says Althea boss after share price slump by Steve Jones November 4, 2022April 29, 2024
Althea heralds ‘very pleasing’ result as revenues spike and losses narrow by Steve Jones August 31, 2022April 29, 2024
Althea shares spike as revenue doubles and operating costs hit ‘all-time low’ by Steve Jones July 12, 2022April 29, 2024
Althea facing ‘defining period’ as company emerges from pandemic by Steve Jones April 27, 2022April 29, 2024
Company news: Althea; Bod; ECS Botanics; LGP; Live Verdure; Creso Pharma; Emyria; Medlab by Martin Lane February 24, 2022April 29, 2024
Althea reports record quarter as medical division rebounds from Covid by Steve Jones January 20, 2022April 29, 2024
Althea bets on dual strategy as CEO predicts big pharma will come knocking ‘sooner than we thought’ by Steve Jones September 23, 2021April 26, 2024
